Cytokine PharmaSciences Names Vidal F. de la Cruz, Ph.D., Vice President, Business Development

Dec 09, 2004, 00:00 ET from Cytokine PharmaSciences, Inc.

    KING OF PRUSSIA, Pa., Dec. 9 /PRNewswire/ -- Cytokine PharmaSciences, Inc.
 today announced the promotion of Vidal F. de la Cruz, Ph.D. to the position of
 Vice President, Business Development.  Dr. de la Cruz joined the Company in
 2001 as Director of Preclinical Development and assumed additional
 responsibilities for business development in 2003.  He received his B.S. in
 biology from Fairleigh Dickinson University and his Ph.D. in cell and
 molecular biology from UCLA.  Dr. de la Cruz also did post-doctoral work at
 the NIH before moving into the biotech industry in 1988.
     "This is a well deserved promotion," stated Denny Willson, President and
 CEO of Cytokine PharmaSciences.  "Vidal has made an important contribution to
 our business over the past three years.  I look forward to what he can
 accomplish in his new role as Vice President of Business Development."
     Cytokine PharmaSciences is a biopharmaceutical company located in King of
 Prussia, Pennsylvania (near Philadelphia).  The company licenses technologies
 from academia and other sources, develops products from those technologies and
 outlicenses the products to third parties for marketing.  For more
 information, go to

SOURCE Cytokine PharmaSciences, Inc.